These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6514398)

  • 1. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.
    Friedlander ML; Russell P; Taylor IW; Hedley DW; Tattersall MH
    Pathology; 1984 Jul; 16(3):301-6. PubMed ID: 6514398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy analysis of borderline epithelial ovarian tumours.
    Lodhi S; Najam S; Pervez S
    J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brenner tumours of the ovary: a study of the histology, immunohistochemistry and cellular DNA content in benign, borderline and malignant ovarian tumours.
    Trebeck CE; Friedlander ML; Russell P; Baird PJ
    Pathology; 1987 Jul; 19(3):241-6. PubMed ID: 3324024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of DNA flow cytometry in borderline malignant ovarian tumors.
    Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
    Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometric analysis of cellular DNA content in epithelial ovarian cancer].
    Arai H; Izumi S; Wada T; Tsutsui F; Yamaoka K; Nozawa S
    Nihon Rinsho; 1992 Oct; 50(10):2439-43. PubMed ID: 1333018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucinous borderline and malignant tumors of the ovary. A clinicopathologic and DNA ploidy study of 92 cases.
    Guerrieri C; Högberg T; Wingren S; Fristedt S; Simonsen E; Boeryd B
    Cancer; 1994 Oct; 74(8):2329-40. PubMed ID: 7922984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of flow cytometric DNA analysis in detecting the presence of malignant cells in ovarian carcinoma peritoneal fluids.
    Kehoe S; Ward K; Luesley D; Chan KK
    Br J Obstet Gynaecol; 1995 Aug; 102(8):656-9. PubMed ID: 7654646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ploidy as a prognostic factor in ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Musgrove EA; Hedley DH; Tattersall MH
    Int J Gynecol Pathol; 1983; 2(1):55-63. PubMed ID: 6307906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients.
    Baak JP; Schipper NW; Wisse-Brekelmans EC; Ceelen T; Bosman FT; van Geuns H; Wils J
    Br J Cancer; 1988 May; 57(5):503-8. PubMed ID: 3395555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular DNA content--a stable feature in epithelial ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Tattersall MH
    Br J Cancer; 1984 Feb; 49(2):173-9. PubMed ID: 6696818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.